What’s new in October

What’s new in October, with links to support, information and other items of interest.

• • Breast cancer drug Truqap now available on PBS
  • Navigating Upper GI Cancer: How Pancare Foundation Can Support
  • New study on bone health in cancer survivors: Your experience matters
  • Living with NET’s October sessions

Breast cancer drug Truqap now available on PBS

In a significant step forward for breast cancer care, the federal government has announced that Truqap – a treatment for locally advanced or metastatic breast cancer – will be added to the Pharmaceutical Benefits Scheme (PBS) from Wednesday 1 October, coinciding with the start of Breast Cancer Awareness Month.

This listing means eligible patients will now pay just $31.60 per script, compared to the previous cost of up to $100,000 for a full course of treatment. Health Minister Mark Butler said the decision is expected to benefit around 3,000 Australians each year. It will also improve survival rates for those with metastatic breast cancer.

The move has been welcomed by advocates and clinicians alike, including Metastatic Breast Cancer Action Australia and oncologist Professor Fran Boyle, who noted that Truqap offers a new option that may delay the need for chemotherapy.

Read the media release about Truqap’s addition to the PBS on Health Minister Mark Butler’s website.

Navigating Upper GI Cancer: How Pancare Foundation Can Support 

Pancare Foundation is dedicated to supporting Australians affected by upper GI cancers. They focus on prevention, early detection, personalised treatment and advancing research. Led by people who understand these challenges, they connect patients with care and provide online communities for support.

Watch the recently released Pancare video Navigating Upper GI Cancer: How Pancare Foundation Can Support on YouTube to learn more.

New study on bone health in cancer survivors: your experience matters 

Bone Health in Cancer Survivorship (BHCS) is seeking participants who have previously been diagnosed with cancer to help explore the long-term effects of treatment on bone health. Led by Dr. Lisa Grech in collaboration with Deakin University and Monash University, the study investigates how therapies like chemotherapy, hormone therapy, and glucocorticoids may contribute to osteoporosis and other bone-related issues. Through a short online survey, participants will share their experiences, lifestyle factors, and the support they’ve received, helping researchers assess current practices and identify barriers to effective bone health management. By taking part, you’ll contribute to vital research that could improve care for future cancer patients.

More information and links to the survey can be found on the flyer here.

Living with NETs October sessions 

This four-week online education program has been designed to support individuals diagnosed with neuroendocrine tumours (NETs) and their carers. The program offers practical information about tests and treatments, strategies for managing challenges, and guidance on improving overall wellbeing. It also provides a safe space for sharing experiences, building confidence, and developing self-advocacy skills. Sessions will run online every Tuesday in October from 1.30pm to 3.30pm (AEDT).

Register via the NeuroEndocrine Cancer Australia website